X
GMED icon

Xponance’s Globus Medical GMED Stock Holding History

Xponance’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
13,523
-4
-0% -$340 0.01% 774
2026
Q1 		$1.17M Buy
13,527
+3,123
+30% +$280K 0.01% 693
2025
Q4 		$908K Sell
10,404
-2,182
-17% -$166K 0.01% 720
2025
Q3 		$721K Sell
12,586
-117
-0.9% -$6.74K 0.01% 821
2025
Q2 		$750K Sell
12,703
-448
-3% -$28.9K 0.01% 799
2025
Q1 		$963K Buy
13,151
+259
+2% +$21.4K 0.01% 704
2024
Q4 		$1.07M Buy
12,892
+767
+6% +$60.5K 0.01% 702
2024
Q3 		$867K Buy
12,125
+54
+0.4% +$3.81K 0.01% 747
2024
Q2 		$827K Sell
12,071
-5,029
-29% -$300K 0.01% 733
2024
Q1 		$917K Buy
17,100
+38
+0.2% +$2.04K 0.01% 747
2023
Q4 		$909K Sell
17,062
-579
-3% -$28.2K 0.01% 706
2023
Q3 		$876K Buy
17,641
+8,008
+83% +$448K 0.01% 693
2023
Q2 		$574K Sell
9,633
-1,016
-10% -$57.9K 0.01% 853
2023
Q1 		$603K Sell
10,649
-35
-0.3% -$2.24K 0.01% 856
2022
Q4 		$794K Buy
10,684
+1,028
+11% +$70K 0.01% 714
2022
Q3 		$575K Sell
9,656
-429
-4% -$25.8K 0.01% 788
2022
Q2 		$566K Buy
10,085
+1,108
+12% +$72.8K 0.01% 813
2022
Q1 		$662K Sell
8,977
-258
-3% -$17.9K 0.01% 772
2021
Q4 		$667K Buy
9,235
+194
+2% +$14.1K 0.01% 787
2021
Q3 		$693K Sell
9,041
-233
-3% -$18.7K 0.01% 736
2021
Q2 		$719K Buy
9,274
+1,143
+14% +$81.3K 0.01% 746
2021
Q1 		$501K Buy
8,131
+107
+1% +$6.78K 0.01% 778
2020
Q4 		$523K Buy
8,024
+90
+1% +$5.17K 0.01% 715
2020
Q3 		$393K Buy
7,934
+1,104
+16% +$56.9K 0.01% 750
2020
Q2 		$326K Buy
+6,830
New +$329K 0.01% 799

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Xponance's GMED Position: Q2 2026 in Review

Xponance reduced its Globus Medical (GMED) stake by 0.03% in Q2 2026, selling an estimated $340 and leaving 13,523 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #774.

Xponance first reported a position in GMED in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.17M in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Xponance held 13,523 shares of Globus Medical worth $1.07M as of Q2 2026.
  • Xponance sold 4 Globus Medical shares in Q2 2026, an estimated $340.
  • Globus Medical made up 0.01% of Xponance's portfolio in Q2 2026, its #774 holding.
  • Xponance first reported a position in Globus Medical in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Globus Medical position peaked at $1.17M in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.